CN Patent

CN1684690A — 用于激素替代疗法的17β－雌二醇/左炔诺孕酮经皮贴剂

Assigned to Bayer Pharma AG · Expires 2005-10-19 · 21y expired

What this patent protects

本发明涉及一种在患者中降低甘油三酸酯水平并实施激素替代疗法的方法，其包括持续经皮给药于药物学可接受的载体中的基本恒定的治疗有效量的雌二醇(17β－雌二醇)和孕酮(左炔诺孕酮(LNG))。

USPTO Abstract

本发明涉及一种在患者中降低甘油三酸酯水平并实施激素替代疗法的方法，其包括持续经皮给药于药物学可接受的载体中的基本恒定的治疗有效量的雌二醇(17β－雌二醇)和孕酮(左炔诺孕酮(LNG))。

Drugs covered by this patent

Patent Metadata

Patent number
CN1684690A
Jurisdiction
CN
Classification
—
Expires
2005-10-19
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Pharma AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.